Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Gallovic MD"'
Autor:
Stiepel RT; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Pena ES; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, USA., Ehrenzeller SA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Gallovic MD; IMMvention Therapeutix, Durham, NC 27701, USA., Lifshits LM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Genito CJ; Department of Microbiology & Immunology, UNC School of Medicine, University of North Carolina, Chapel Hill, USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, USA; Department of Microbiology & Immunology, UNC School of Medicine, University of North Carolina, Chapel Hill, USA. Electronic address: ainsliek@email.unc.edu.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Nov; Vol. 351, pp. 883-895. Date of Electronic Publication: 2022 Oct 12.
Autor:
Gallovic MD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Junkins RD; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Sandor AM; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Pena ES; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Sample CJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA., Mason AK; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA., Arwood LC; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA., Sahm RA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, USA., Sempowski GD; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA., Ting JP; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Institute for Inflammatory Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Center for Translational Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: jenny_ting@med.unc.edu.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Jul; Vol. 347, pp. 356-368. Date of Electronic Publication: 2022 May 18.
Autor:
Batty CJ; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA., Gallovic MD; Immvention Therapeutix, Durham, NC, USA., Williams J; Nuventra Pharma Sciences, Raleigh, NC, USA., Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, NC, USA; Department of Microbiology and Immunology, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Jun 25; Vol. 622, pp. 121839. Date of Electronic Publication: 2022 May 24.
Autor:
Johnson BM; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Uchimura T; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Gallovic MD; Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Thamilarasan M; Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Chou WC; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Gibson SA; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Deng M; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Oral and Craniofacial Biomedicine Program, School of Dentistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Tam JW; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Batty CJ; Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Williams J; Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Matsushima GK; Neuroscience Center, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Bachelder EM; Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Ainslie KM; Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Markovic-Plese S; Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Ting JP; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC; jenny_ting@med.unc.edu.; Neuroscience Center, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Center for Translational Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and.; Institute for Inflammatory Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 May 01; Vol. 206 (9), pp. 2015-2028. Date of Electronic Publication: 2021 Apr 05.
Autor:
Steipel RT; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Gallovic MD; IMMvention Therapeutix, Durham, NC, USA., Batty CJ; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill/North Carolina State University, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, USA. Electronic address: ainsliek@email.unc.edu.
Publikováno v:
Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2019 Dec; Vol. 105, pp. 110070. Date of Electronic Publication: 2019 Aug 09.
Autor:
Watkins-Schulz R; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Tiet P; Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina, Chapel Hill, NC, 27599, USA., Gallovic MD; Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina, Chapel Hill, NC, 27599, USA., Junkins RD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Batty C; Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina, Chapel Hill, NC, 27599, USA., Bachelder EM; Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina, Chapel Hill, NC, 27599, USA., Ainslie KM; Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina, Chapel Hill, NC, 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Ting JPY; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Institute for Inflammatory Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Center for Translational Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. Electronic address: jenny_ting@med.unc.edu.
Publikováno v:
Biomaterials [Biomaterials] 2019 Jun; Vol. 205, pp. 94-105. Date of Electronic Publication: 2019 Mar 14.
Autor:
Krovi SA; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Gallovic MD; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Keller AM; Department of Microbiology, Ohio State University, Columbus, OH 43210, USA., Bhat M; Department of Microbiology, Ohio State University, Columbus, OH 43210, USA., Tiet P; United Therapeutics, Durham, NC 27709, USA., Chen N; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Collier MA; Avanti Polar Lipids, Alabaster, AL 35007, USA., Gurysh EG; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Pino EN; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Johnson MM; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Shamim Hasan Zahid M; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Cottrell ML; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Pirone JR; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Kashuba AD; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Kwiek JJ; Department of Microbiology, Ohio State University, Columbus, OH 43210, USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2018 Dec 01; Vol. 552 (1-2), pp. 371-377. Date of Electronic Publication: 2018 Oct 08.
Autor:
Chen N; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Gallovic MD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Tiet P; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Ting JP; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA; Institute for Inflammatory Diseases, University of North Carolina, Chapel Hill, NC, USA; Center for Translational Immunology, University of North Carolina, Chapel Hill, NC, USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ebacheld@email.unc.edu.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2018 Nov 10; Vol. 289, pp. 114-124. Date of Electronic Publication: 2018 Sep 24.
Autor:
Johnson MM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Collier MA; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Hoang KV; Texas Biomedical Research Institute , San Antonio , Texas 78227 , United States., Pino EN; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Graham-Gurysh EG; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Gallovic MD; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Zahid MSH; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Chen N; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Schlesinger L; Texas Biomedical Research Institute , San Antonio , Texas 78227 , United States., Gunn JS; Department of Microbial Infection and Immunity , The Ohio State University , Columbus , Ohio 43210 , United States., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States.; Department of Microbiology and Immunology , University of North Carolina-Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2018 Nov 05; Vol. 15 (11), pp. 5336-5348. Date of Electronic Publication: 2018 Oct 17.
Autor:
Collier MA, Junkins RD, Gallovic MD, Johnson BM, Johnson MM, Macintyre AN; Duke Human Vaccine Institute , Duke University Medical Center , Durham , North Carolina 27710 , United States., Sempowski GD; Duke Human Vaccine Institute , Duke University Medical Center , Durham , North Carolina 27710 , United States., Bachelder EM, Ting JP, Ainslie KM
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2018 Nov 05; Vol. 15 (11), pp. 4933-4946. Date of Electronic Publication: 2018 Oct 15.